Renalytix plc financial data

Symbol
RNLX on Nasdaq, RTNXF on OTC
Industry
Services-Medical Laboratories
Location
Finsgate, 5 7 Cranwood Street, London, United Kingdom
State of incorporation
DE
Fiscal year end
June 30
Former names
Renalytix AI plc (to 6/25/2021)
Latest financial report
10-K - Q2 2024 - Sep 30, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 66.9 % -68.4%
Debt-to-equity -267 % -262%
Return On Equity 471 %
Return On Assets -281 % -116%
Operating Margin -1.29K % -4.26%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 166M shares +74.6%
Common Stock, Shares, Outstanding 154M shares +64.6%
Entity Public Float 24.7M USD -45%
Common Stock, Value, Issued 478K USD +67.1%
Weighted Average Number of Shares Outstanding, Basic 108M shares +31.6%
Weighted Average Number of Shares Outstanding, Diluted 108M shares +31.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.29M USD -32.7%
Cost of Revenue 2.13M USD -20.5%
General and Administrative Expense 19.8M USD -31.1%
Operating Income (Loss) -29.6M USD +29.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -33.5M USD +26.6%
Income Tax Expense (Benefit) 4K USD +100%
Net Income (Loss) Attributable to Parent -33.5M USD +26.6%
Earnings Per Share, Basic -0.31 USD/shares +43.6%
Earnings Per Share, Diluted -0.31 USD/shares +43.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.68M USD -81%
Accounts Receivable, after Allowance for Credit Loss, Current 722K USD -6.96%
Assets, Current 6.12M USD -77.2%
Property, Plant and Equipment, Net 216K USD -79%
Operating Lease, Right-of-Use Asset 0 USD -100%
Intangible Assets, Net (Excluding Goodwill) 869K USD -17.2%
Assets 7.97M USD -74%
Accounts Payable, Current 1.75M USD -15.1%
Employee-related Liabilities, Current 388K USD -90%
Accrued Liabilities, Current 3.35M USD -49.5%
Liabilities, Current 11.5M USD -28.8%
Operating Lease, Liability, Noncurrent 0 USD -100%
Other Liabilities, Noncurrent 14K USD
Liabilities 15.8M USD -33.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.44M USD +0.48%
Retained Earnings (Accumulated Deficit) -212M USD -18.8%
Stockholders' Equity Attributable to Parent -7.85M USD -213%
Liabilities and Equity 7.97M USD -74%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.5M USD -33.5%
Net Cash Provided by (Used in) Financing Activities -1.07M USD -12.8%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 162M shares 0%
Common Stock, Shares, Issued 154M shares +64.6%
Common Stock, Par or Stated Value Per Share 0 GBP/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -10.8M USD -4.84%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 41.3M USD -36.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 292K USD
Deferred Tax Assets, Valuation Allowance 55.4M USD +21.6%
Operating Lease, Liability 45K USD -73.7%
Depreciation 200K USD -33.3%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -17.3M USD -128%
Lessee, Operating Lease, Liability, to be Paid 46K USD -75%
Property, Plant and Equipment, Gross 515K USD -72.6%
Operating Lease, Liability, Current 45K USD -65.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year One 46K USD -66.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1K USD -92.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD
Deferred Tax Assets, Operating Loss Carryforwards 46M USD +21.8%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD
Operating Lease, Payments 74K USD -42.6%
Operating Leases, Future Minimum Payments, Due in Two Years 153K USD +84.3%
Depreciation, Depletion and Amortization 127K USD -2.31%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 162K USD
Deferred Tax Assets, Net of Valuation Allowance 82K USD -81.9%
Share-based Payment Arrangement, Expense 1.71M USD -41.8%
Operating Leases, Future Minimum Payments, Due in Three Years 45K USD -45.8%
Operating Leases, Future Minimum Payments Due 360K USD +30%